Drugs / Senna Alexandrina Miller
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00931853 | Sep 2010 → Dec 2011 | constipation disorder | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00994851 | Sep 2009 → Aug 2012 | constipation disorder | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Senna Alexandrina Miller | “Combination Naturetti® (Cassia Fistula + Senna Alexandrina Miller) in the Chronic Functional Constipation” NCT00931853 ↗1“Combination Naturetti® (Cassia Fistula + Senna Alexandrina Miller)” NCT00994851 ↗ |
| Route | Oral | “Route of administration: oral” NCT00994851 ↗ |